Results 171 to 180 of about 129,091 (314)

Bridging symptoms of posttraumatic stress disorder, complex posttraumatic stress disorder and posttraumatic growth: a network analysis. [PDF]

Eur J Psychotraumatol
Berle D, Nag R, Gai Y, Badawi A, Starcevic V, Baggio S.   +5 more
europepmc   +1 more source

Firearms as a Market‐Driven Epidemic: Potential Pathways to Reduce Preventable Firearm‐Related Harm in the United States

The Milbank Quarterly, EarlyView.
Policy Points For half a century, firearm‐related deaths and injuries have been endemic in the United States, with COVID‐19 contributing to a record high of 48,830 deaths in 2021, an epidemic rate increase. By 2023, national trends masked a significant 10‐fold difference in firearm‐related death rates among states.
ESZTER RIMÁNYI, JONATHAN D. QUICK, STEPHEN W. HARGARTEN, CHARLES C. BRANAS, SANDRO GALEA, NASON MAANI, JONATHAN LOWY, ZAIN HUSSAIN, NICHOLAS HOFFMANN   +8 more
wiley   +1 more source

Role of Intelligence in Posttraumatic Stress Disorder Development: A Systematic Review. [PDF]

J Intell
Lacombe M, Pérez-García AM, Ramírez-Uclés I.   +2 more
europepmc   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Negative Urgency Amplifies Alcohol Demand in Individuals with Posttraumatic Stress Disorder. [PDF]

J Stud Alcohol Drugs
DiPaolo LR, Magri TD, Meshesha LZ, Read JP.   +3 more
europepmc   +1 more source

A latent class analysis of clinical complexity: Secondary analysis of the collaboration leading to addiction treatment and recovery from other stresses (CLARO) randomized trial

Addiction, EarlyView.
Abstract Background and aims Individuals with opioid use disorder (OUD) frequently present with co‐occurring mental health conditions such as depression and posttraumatic stress disorder (PTSD), along with other mental health substance use disorders, physical health conditions and social determinants that together comprise ‘clinical complexity ...
Megan S. Schuler, Rebecca Weir, Colleen M. McCullough, Grace M. Hindmarch, Beth Ann Griffin, Kirsten Becker, Lisa S. Meredith, Katherine E. Watkins   +7 more
wiley   +1 more source

Treating Acute Stress Disorder Following Mild Traumatic Brain Injury [PDF]

, 2003
Bryant, Richard, Guthrie, Rachel M, Nixon, Reginald David, Moulds, Michelle   +3 more
core   +1 more source

Network analysis of posttraumatic stress disorder and posttraumatic growth among patients with an intestinal stoma. [PDF]

Asia Pac J Oncol Nurs
Jiangenuer L, Wang X, Tuerdebieke W, Aihemaitiniyazi S, Liu C, Xu Z, Zhang X.   +6 more
europepmc   +1 more source

Extended‐release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18‐month retrospective case series

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Poppy seed tea (PST) contains unpredictable opioid concentrations, destabilising tolerance and increasing overdose risk. Extended‐release buprenorphine (BUP‐XR) provides sustained coverage without daily dosing. Methods Eighteen‐month follow‐up of adults (N = 3) with opioid use disorder (OUD) involving PST in Australia.
John McMaster, Saumiya Seshakumaran, Hesitha Abeysundera, Isha Tipirneni, Rita Hormiz   +4 more
wiley   +1 more source

Posttraumatic Stress Disorder Treatment Decision Aid: User-Centered Design Update Approach. [PDF]

JMIR Form Res
Larsen SE, Merrick C, Zisman-Ilani Y, Eden KB, Treworgy S, Hamblen JL.   +5 more
europepmc   +1 more source